Progressive-Supranuclear-Palsy-Information-Page

Progressive-Supranuclear-Palsy-Information-Page

Progressive Supranuclear Palsy Information Page

What research is being done?

PSP is one of the diseases being studied as part of the NINDS Parkinsons Disease Biomarkers Program, which aims to discover ways to identify individuals at risk for developing Parkinson's and related disorders, and to track disease progression.  Genetis studies may identify underlying genetic causes and identify specific disease-causing mutations, which could point to additional targets for therapy development.  Investigators are also developing animal models of PSP and other protein tau-related disorders, for research on disease mechanisms and preclinical testing of potential drugs. Other research focuses on therapies that aim to treat teh symptoms of PSP.

Information from the National Library of Medicine’s MedlinePlus
Progressive Supranuclear Palsy

×
What research is being done?

PSP is one of the diseases being studied as part of the NINDS Parkinsons Disease Biomarkers Program, which aims to discover ways to identify individuals at risk for developing Parkinson's and related disorders, and to track disease progression.  Genetis studies may identify underlying genetic causes and identify specific disease-causing mutations, which could point to additional targets for therapy development.  Investigators are also developing animal models of PSP and other protein tau-related disorders, for research on disease mechanisms and preclinical testing of potential drugs. Other research focuses on therapies that aim to treat teh symptoms of PSP.

Information from the National Library of Medicine’s MedlinePlus
Progressive Supranuclear Palsy

PSP is one of the diseases being studied as part of the NINDS Parkinsons Disease Biomarkers Program, which aims to discover ways to identify individuals at risk for developing Parkinson's and related disorders, and to track disease progression.  Genetis studies may identify underlying genetic causes and identify specific disease-causing mutations, which could point to additional targets for therapy development.  Investigators are also developing animal models of PSP and other protein tau-related disorders, for research on disease mechanisms and preclinical testing of potential drugs. Other research focuses on therapies that aim to treat teh symptoms of PSP.

Information from the National Library of Medicine’s MedlinePlus
Progressive Supranuclear Palsy


Definition
Definition
Treatment
Treatment
Prognosis
Prognosis
Clinical Trials
Clinical Trials
Organizations
Organizations
Publications
Publications

Progressive Supranuclear Palsy (PSP) fact sheet compiled by the National Institute of Neurological Disorders and Stroke (NINDS).

The National Institute on Aging and the NINDS' brochure on Frontotemporal Disorders.

Booklet about dementias that affect personality, behavior, language, and movement, and how they are diagnosed and treated.